Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine
Astrid M. Cardona-Acosta, Carlos A. Bolaños‐Guzmán
Topics & Concepts
AntidepressantAnhedoniaDopamineKetamineNeurosciencePsychologyMonoamine neurotransmitterMajor depressive disorderPsychiatryMedicinePharmacologyHippocampusSerotoninAmygdalaReceptorInternal medicineTreatment of Major DepressionTryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior